Michael A. Straker

University of Maryland, College Park

Papers

1

Total Citations

2

H-Index

1

About

Michael A. Straker is a pioneering biomedical engineer whose work centers on advanced oral drug delivery systems, gastrointestinal (GI) biomechanics, and microinjection technologies. His most notable contribution is the development of the first anchoring injector for prolonged drug dosing in the GI tract—a breakthrough that enables localized, sustained drug release lasting over 50 times longer than conventional pills. This innovation directly addresses the critical challenge of mucosal barrier exclusion, which has long limited the efficacy of oral biologics and sensitive therapeutics. Straker’s research has already garnered early citations, signaling its transformative potential for patient-friendly treatments of chronic diseases. By merging microfabrication with mucosal biology, he has opened new avenues for non-invasive, long-acting therapies that could replace frequent injections or infusions. His work is particularly impactful for conditions requiring consistent drug levels, such as diabetes or autoimmune disorders. Straker’s achievements mark him as a rising leader in drug delivery engineering, with his anchoring injector poised to redefine oral administration standards.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Anchoring Injector for Prolonged Dosing of Drugs in the Gastrointestinal Tract
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: University of Maryland, College Park

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago